BioCentury
ARTICLE | Company News

New Zealand Pharmaceuticals Ltd., Summit deal

September 7, 2009 7:00 AM UTC

Summit Corp. sold its chemistry services subsidiary Dextra Laboratories Ltd. to CMO New Zealand for £950,000 ($1.6 million) in cash. New Zealand Pharmaceuticals said Dextra's contract synthesis and ma...